Effects of statins on platelet inhibition by a high loading dose of clopidogrel
about
Clopidogrel: an updated and comprehensive reviewPercutaneous coronary intervention: recommendations for good practice and training.Effects of drug interactions on biotransformation and antiplatelet effect of clopidogrel in vitro.Clinical importance of aspirin and clopidogrel resistanceLack of clopidogrel-CYP3A4 statin interaction in patients with acute coronary syndromeConcomitant use of clopidogrel and statins and risk of major adverse cardiovascular events following coronary stent implantation.Clopidogrel use in coronary artery disease.Combination of clopidogrel and statins: a hypothetical interaction or therapeutic dilemma?Clopidogrel resistance--the cardiologist's perspective.Aspirin and clopidogrel response variability: review of the published literatureSimultaneous administration of high-dose atorvastatin and clopidogrel does not interfere with platelet inhibition during percutaneous coronary intervention.Genetic variation of CYP2C19 affects both pharmacokinetic and pharmacodynamic responses to clopidogrel but not prasugrel in aspirin-treated patients with coronary artery disease.Residual platelet reactivity: predicting short- and long-term clinical outcome in patients undergoing percutaneous coronary revascularization.Antiplatelet therapy in acute coronary syndromes.Antiplatelet function variability in clopidogrel-treated patients: need for new antiplatelet agents.Drug interactions with statins.Drug-drug interaction with statins.Clinical pharmacokinetics and pharmacodynamics of clopidogrel.Platelet GP IIb-IIIa Receptor Antagonists in Primary Angioplasty: Back to the Future.The Impact of CYP2C19 Loss-of-Function Polymorphisms, Clinical, and Demographic Variables on Platelet Response to Clopidogrel Evaluated Using Impedance Aggregometry.Clopidogrel: cardiologists' panacea or neurologists' headache?1-[4-(4-Nitro-phen-yl)piperazin-1-yl]-2-(4,5,6,7-tetra-hydro-thieno[3,2-c]pyridin-5-yl)ethanone.2-Chloro-ethyl 2-(2-chloro-phen-yl)-2-(4,5,6,7-tetrahydro-thieno[3,2-c]pyridin-5-yl)acetate.3-Bromo-propyl 2-(2-chloro-phen-yl)-2-(4,5,6,7-tetra-hydro-thieno[3,2-c]pyridin-5-yl)acetate.5-(2-Chloro-benz-yl)-4,5,6,7-tetra-hydro-thieno[3,2-c]pyridin-2-yl acetateUnderstanding clopidogrel efficacy in the presence of cytochrome P450 polymorphismDoes the use of statins compromise the effectiveness of platelet inhibition by clopidogrel?Effect of atorvastatin on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel in healthy subjects.Epidemiology of CYP3A4-mediated clopidogrel drug-drug interactions and their clinical consequences.Multiple antiplatelet effects of clopidogrel are not modulated by statin type in patients undergoing percutaneous coronary intervention.Clopidogrel anti-platelet effect: an evaluation by optical aggregometry, impedance aggregometry, and the platelet function analyzer (PFA-100).Inhibition behavior of fructus psoraleae's ingredients towards human carboxylesterase 1 (hCES1).
P2860
Q28219411-364420F2-A6DB-48EE-846F-C7D6A1C2F502Q30479477-F980A064-65EB-4005-9EBC-683881E8E040Q34339780-390CE80D-8FE0-402C-9210-7819A005ED37Q34390050-A3A399C7-FF7D-413D-865D-44B55730B6C1Q35583381-C69C48FE-1CF3-4686-BFDD-1D93AEFEDA56Q36088008-09211B4A-D10E-4588-B26B-5E12EB0DBB8DQ36351993-803290F6-7063-4230-A618-5F9FBBEE1D9AQ36407222-F15AAE87-B613-47A5-A850-ECA64B05E405Q36819608-7D1A7B77-DA16-4BD1-9786-8461E7FF93BDQ36932221-8A6EE25A-C50B-424F-94AA-B72A450D5DFCQ36992366-6B390DAF-AF67-4442-9F3D-194127395C0EQ37259929-CEFC845E-A622-4CC9-BF95-9AC7507969A7Q37765291-CC07C034-8ACC-4F20-8C4F-5EEA6F7055AAQ37798110-FBD7F5FB-255A-4DC9-AB6E-089C7F013448Q37914924-1734535B-BEA4-4F2E-8731-0D4FD06868AEQ38155016-57649156-65F3-4D54-B0B6-85FF61839810Q38177333-0F4FB9E4-D493-459D-B7A3-69F54A3F9B4EQ38307535-89EA93E5-1FAE-4B27-A428-08B533DE78DCQ38547727-22105383-D05E-4FDA-B6DB-65F34F8AFEEDQ40000336-8D7FB41F-C4C8-40E9-8613-204D58FEF5E7Q40393685-0701BF62-4E34-4C78-B5AB-1345F43F94E2Q41443581-E154B72F-26A4-4ED0-9A4C-53D769DB00B7Q41512891-921C4037-4D07-4458-989D-8E7C07DFC2FBQ41864523-6014E7E0-7DF4-4B33-9B38-EA9B2BC2E40DQ41902254-AD6DC81B-968A-4F9B-B339-7BA3C7244D3CQ42425352-C077EACB-2D8A-407E-9231-D4849241D8EAQ44941568-FAE95F33-5ED2-4B25-8DB6-029BCD458756Q46234082-BC2911F1-C4B9-4BBB-803F-1E0DF158FF80Q46320953-1D8B092C-2CD7-483C-99D6-FB9184A5F741Q46374395-7E8FD5C5-5E25-445D-9B0E-FA9A3BF85405Q50676873-1BAB1817-AD43-4409-9B1E-5BF7B5387D47Q52665376-0A414553-E8AD-449F-953B-1B79AB63A282
P2860
Effects of statins on platelet inhibition by a high loading dose of clopidogrel
description
2003 nî lūn-bûn
@nan
2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Effects of statins on platelet inhibition by a high loading dose of clopidogrel
@ast
Effects of statins on platelet inhibition by a high loading dose of clopidogrel
@en
Effects of statins on platelet inhibition by a high loading dose of clopidogrel
@nl
type
label
Effects of statins on platelet inhibition by a high loading dose of clopidogrel
@ast
Effects of statins on platelet inhibition by a high loading dose of clopidogrel
@en
Effects of statins on platelet inhibition by a high loading dose of clopidogrel
@nl
prefLabel
Effects of statins on platelet inhibition by a high loading dose of clopidogrel
@ast
Effects of statins on platelet inhibition by a high loading dose of clopidogrel
@en
Effects of statins on platelet inhibition by a high loading dose of clopidogrel
@nl
P2093
P3181
P1433
P1476
Effects of statins on platelet inhibition by a high loading dose of clopidogrel
@en
P2093
Christian Schulz
Felicitas Besta
Iris Müller
Meinrad Gawaz
Steffen Massberg
Zhongyan Li
P304
P3181
P356
10.1161/01.CIR.0000099507.32936.C0
P407
P577
2003-11-04T00:00:00Z